• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人淋巴组织中表达Tac抗原的淋巴细胞的免疫组织学定位及免疫表型

Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.

作者信息

Miyawaki T, Ohzeki S, Ikuta N, Seki H, Taga K, Taniguchi N

出版信息

J Immunol. 1984 Dec;133(6):2996-3000.

PMID:6092463
Abstract

A monoclonal anti-Tac antibody has been identified as a putative antibody against the human interleukin 2 (IL 2) receptor. In the present study, anti-Tac antibody was used to determine the location of cells expressing IL 2 receptors in frozen sections of human lymph nodes and tonsils by means of an immunoperoxidase technique. It was found that a substantial number of lymphoid cells reactive with anti-Tac antibody were present in these tissues. The majority of the Tac-positive cells were located in the paracortical and interfollicular regions of lymph nodes and tonsils, whereas only a few Tac-positive cells were scattered in the mantle zones and germinal centers of the secondary follicles. In contrast, no Tac-positive cells were demonstrated on cytocentrifuge preparations of peripheral blood lymphocytes from some of tissue donors, as evaluated by the same technique. In some experiments, a double-marker immunofluorescence analysis with the use of different fluorochromes, fluorescein isothiocyanate (FITC), and tetramethylrhodamine isothiocyanate (TRITC) was applied to characterize the phenotypes of cells expressing Tac antigen. Double staining with TRITC and FITC, respectively, for the identification of Tac-positive cells and T cells, showed that Tac-positive cells in lymph nodes and tonsils almost exclusively co-expressed a pan-T cell marker, Leu-1 antigen, that probably does not belong to non-T cell lineages. About 80% of Tac-positive cells were Leu-3 (helper/inducer) positive, and 20% of them Leu-2 (suppressor/cytotoxic) positive. These observations imply the plausible notion that an IL 2-mediated immune activation of T cells may actually occur in local lymphoid organs.

摘要

一种单克隆抗 Tac 抗体已被鉴定为一种针对人白细胞介素 2(IL - 2)受体的推定抗体。在本研究中,利用免疫过氧化物酶技术,使用抗 Tac 抗体来确定人淋巴结和扁桃体冰冻切片中表达 IL - 2 受体的细胞位置。结果发现,这些组织中存在大量与抗 Tac 抗体反应的淋巴细胞。大多数 Tac 阳性细胞位于淋巴结和扁桃体的副皮质区和滤泡间区,而只有少数 Tac 阳性细胞散在于次级滤泡的套区和生发中心。相比之下,通过相同技术评估,一些组织供体的外周血淋巴细胞细胞离心涂片上未显示 Tac 阳性细胞。在一些实验中,使用不同的荧光染料,异硫氰酸荧光素(FITC)和四甲基异硫氰酸罗丹明(TRITC)进行双标记免疫荧光分析,以表征表达 Tac 抗原的细胞表型。分别用 TRITC 和 FITC 进行双重染色以鉴定 Tac 阳性细胞和 T 细胞,结果显示淋巴结和扁桃体中的 Tac 阳性细胞几乎只共同表达一种泛 T 细胞标志物 Leu - 1 抗原,该抗原可能不属于非 T 细胞谱系。约 80%的 Tac 阳性细胞 Leu - 3(辅助/诱导)阳性,20%的细胞 Leu - 2(抑制/细胞毒性)阳性。这些观察结果暗示了一个合理的观点,即 T 细胞的 IL - 2 介导的免疫激活实际上可能发生在局部淋巴器官中。

相似文献

1
Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.人淋巴组织中表达Tac抗原的淋巴细胞的免疫组织学定位及免疫表型
J Immunol. 1984 Dec;133(6):2996-3000.
2
Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue.
J Immunol. 1985 Jun;134(6):3751-5.
3
Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid.用破伤风类毒素免疫后,循环人T细胞上T细胞活化(Tac)抗原和Ia决定簇的顺序表达。
J Immunol. 1983 Aug;131(2):731-5.
4
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.白细胞介素2(IL - 2)可上调人类未致敏外周血淋巴细胞亚群上其自身的受体,并触发这些细胞的增殖。
J Immunol. 1986 Apr 1;136(7):2463-9.
5
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.用人白细胞介素2及其受体的单克隆抗体对人麻风性肉芽肿中的细胞进行原位鉴定。
J Immunol. 1984 Jun;132(6):3085-90.
6
Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.淋巴细胞活化抗原。I. 一种单克隆抗体,抗Act I,定义了一种新的晚期淋巴细胞活化抗原。
J Immunol. 1984 Oct;133(4):1857-62.
7
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.人类滤泡树突状细胞表达CR1、CR2和CR3补体受体抗原。
J Immunol. 1985 Oct;135(4):2687-94.
8
[A study of lymphocyte subsets in human normal tonsil and lymph node].[人类正常扁桃体和淋巴结中淋巴细胞亚群的研究]
Shi Yan Sheng Wu Xue Bao. 1989 Mar;22(1):75-85.
9
Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.白细胞介素-2受体(Tac抗原)在成人T细胞白血病中的异常表达。
Princess Takamatsu Symp. 1984;15:253-8.
10
Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.白细胞介素-2受体在逆转录病毒相关成人T细胞白血病中的表达
Princess Takamatsu Symp. 1984;15:259-68.

引用本文的文献

1
In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.霍奇金淋巴瘤中T细胞亚群、自然杀伤样细胞和巨噬细胞的原位定量分析:浸润密度的数量和质量取决于组织病理学亚型。
Blut. 1986 Jul;53(1):49-58. doi: 10.1007/BF00320582.
2
Lymphoid immunohistochemistry of macaque primates.猕猴灵长类动物的淋巴组织免疫组化
Clin Exp Immunol. 1988 Dec;74(3):435-42.
3
Modulation of intestinal immune reactivity by interleukin 2. Phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa.
白细胞介素2对肠道免疫反应性的调节。人肠黏膜淋巴因子激活的杀伤细胞的表型和功能分析。
Dig Dis Sci. 1988 Oct;33(10):1305-15. doi: 10.1007/BF01536684.
4
Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.反应性淋巴增生性病变、霍奇金病及非霍奇金淋巴瘤中带有白细胞介素-2受体(TAC抗原)的淋巴细胞分布:300例免疫组织学研究
Am J Pathol. 1987 Apr;127(1):27-37.
5
Interleukin-2 effects on human B cells activated in vivo.
J Clin Immunol. 1987 Jul;7(4):277-87. doi: 10.1007/BF00915548.
6
Expression of Tac antigen in B cell lymphomas.Tac抗原在B细胞淋巴瘤中的表达。
Clin Exp Immunol. 1986 Aug;65(2):354-62.
7
Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.霍奇金病外周血和脾脏T淋巴细胞的功能评估
Br J Cancer. 1987 Dec;56(6):800-2. doi: 10.1038/bjc.1987.293.